|
CA2687147C
(en)
*
|
2007-05-11 |
2016-08-23 |
Temasek Life Sciences Laboratory Limited |
H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance
|
|
AU2016202118B2
(en)
*
|
2009-03-20 |
2017-10-26 |
Amgen Inc. |
Carrier immunoglobulins and uses thereof
|
|
US8771693B2
(en)
|
2009-10-27 |
2014-07-08 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2012125724A1
(en)
|
2011-03-14 |
2012-09-20 |
Beth Israel Deaconess Medical Center |
Methods and compositions for the treatment of proliferative disorders
|
|
WO2012149334A2
(en)
|
2011-04-27 |
2012-11-01 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
WO2012162698A1
(en)
|
2011-05-26 |
2012-11-29 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the treatment of immune disorders
|
|
ES2797448T3
(es)
|
2011-08-01 |
2020-12-02 |
Bio Rad Laboratories |
Sistema de captura de células
|
|
US10466160B2
(en)
|
2011-08-01 |
2019-11-05 |
Celsee Diagnostics, Inc. |
System and method for retrieving and analyzing particles
|
|
AU2013271378A1
(en)
|
2012-06-07 |
2014-12-18 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the inhibition of Pin1
|
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
|
CN105283196B
(zh)
*
|
2013-03-15 |
2018-10-12 |
贝丝以色列女执事医疗中心 |
用于产生和使用构象-特异性抗体的方法和组合物
|
|
US9708375B2
(en)
|
2013-03-15 |
2017-07-18 |
Amgen Inc. |
Inhibitory polypeptides specific to WNT inhibitors
|
|
US10391490B2
(en)
|
2013-05-31 |
2019-08-27 |
Celsee Diagnostics, Inc. |
System and method for isolating and analyzing cells
|
|
WO2015035215A1
(en)
|
2013-09-05 |
2015-03-12 |
Amgen Inc. |
Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles
|
|
US10156562B2
(en)
|
2014-05-16 |
2018-12-18 |
Amgen Inc. |
Assay for detecting Th1 and Th2 cell populations
|
|
WO2016011265A2
(en)
|
2014-07-17 |
2016-01-21 |
Beth Israel Deaconess Medical Center, Inc. |
Biomarkers for pin1-associated disorders
|
|
US9968579B2
(en)
|
2014-07-17 |
2018-05-15 |
Beth Isreal Deaconess Medical Center, Inc. |
ATRA for modulating Pin1 activity and stability
|
|
US10548864B2
(en)
|
2015-03-12 |
2020-02-04 |
Beth Israel Deaconess Medical Center, Inc. |
Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
|
|
WO2018017797A1
(en)
*
|
2016-07-22 |
2018-01-25 |
Georgia State Universtiy Research Foundation |
Monoclonal antibodies to b virus and their use for identification of b virus specific reactive peptides
|
|
JP7672196B2
(ja)
|
2017-03-14 |
2025-05-07 |
アムジエン・インコーポレーテツド |
細胞培養において産生される抗体の総非フコシル化グリコフォームの調節
|
|
CN111295245B
(zh)
|
2017-08-29 |
2021-03-16 |
伯乐实验室有限公司 |
用于分离和分析细胞的系统和方法
|
|
KR20200135781A
(ko)
|
2018-03-26 |
2020-12-03 |
암젠 인크 |
세포 배양에서 생산된 항체의 총 비푸코실화 당형태
|
|
USD903413S1
(en)
|
2018-08-09 |
2020-12-01 |
Sharkninja Operating Llc |
Cooking basket
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
US10633693B1
(en)
|
2019-04-16 |
2020-04-28 |
Celsee Diagnostics, Inc. |
System and method for leakage control in a particle capture system
|
|
US11339190B2
(en)
*
|
2020-04-21 |
2022-05-24 |
Rush University Medical Center |
Peptides for the treatment of covid-19
|
|
JP7413408B2
(ja)
|
2019-05-07 |
2024-01-15 |
バイオ－ラッド ラボラトリーズ インコーポレイテッド |
自動化された単一細胞処理のためのシステムおよび方法
|
|
US11273439B2
(en)
|
2019-05-07 |
2022-03-15 |
Bio-Rad Laboratories, Inc. |
System and method for target material retrieval from microwells
|
|
JP7356519B2
(ja)
*
|
2019-06-14 |
2023-10-04 |
バイオ－ラッド ラボラトリーズ インコーポレイテッド |
自動化された単一細胞処理及び解析のためのシステム及び方法
|
|
MX2022003461A
(es)
|
2019-09-26 |
2022-04-19 |
Amgen Inc |
Metodos de produccion de composiciones de anticuerpos.
|
|
EP4107180A4
(en)
*
|
2020-02-19 |
2024-05-08 |
United Biomedical Inc. |
DESIGNER PEPTIDES AND PROTEINS FOR THE DETECTION, PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)
|
|
CN112500498B
(zh)
*
|
2020-02-26 |
2022-09-06 |
四川大学 |
新型冠状病毒疫苗及其制备方法和应用
|
|
EP3872091B1
(en)
|
2020-02-26 |
2023-06-14 |
VIR Biotechnology, Inc. |
Antibodies against sars-cov-2
|
|
WO2021190980A1
(en)
*
|
2020-03-22 |
2021-09-30 |
Quadrucept Bio Limited |
Multimers for viral strain evolution
|
|
US20230250156A1
(en)
*
|
2020-03-22 |
2023-08-10 |
Quadrucept Bio Limited |
Multimers for viral strain evolution
|
|
CN113429476A
(zh)
*
|
2020-03-23 |
2021-09-24 |
泰州迈博太科药业有限公司 |
一种结合冠状病毒的双功能融合蛋白、其制备方法及应用
|
|
WO2021190500A1
(zh)
*
|
2020-03-25 |
2021-09-30 |
神州细胞工程有限公司 |
SARS-CoV-2和SARS-CoV交叉中和抗体的制备及应用
|
|
WO2021198220A1
(en)
*
|
2020-03-30 |
2021-10-07 |
Allero Therapeutics B.V. |
Treatment and prevention of secondary inflammation in patients suffering from a viral infection
|
|
WO2021201679A1
(en)
|
2020-04-01 |
2021-10-07 |
Kiadis Pharma Intellectual Property B.V. |
Compositions and methods targeting coronaviruses
|
|
US20230106770A1
(en)
*
|
2020-04-06 |
2023-04-06 |
Phylex Biosciences, Inc. |
Reagents and methods for preventing, treating or limiting severe acute respiratory syndrome (SARS) coronavirus infection
|
|
EP4132579A4
(en)
|
2020-04-10 |
2024-05-22 |
Invivyd, Inc. |
CORONAVIRUS S-PROTEIN SPECIFIC COMPOUNDS AND USES THEREOF
|
|
WO2021214467A1
(en)
*
|
2020-04-23 |
2021-10-28 |
Cellbio |
A diagnostic tool improvement comprising a pathogen binding molecule
|
|
US20230399384A1
(en)
*
|
2020-04-24 |
2023-12-14 |
The Board Of Regents Of The University Of Texas System |
Antibodies to coronavirus spike protein and methods of use thereof
|
|
WO2021213520A1
(en)
*
|
2020-04-24 |
2021-10-28 |
Single Cell Technology, Inc. |
Anti-sars coronavirus-2 spike protein antibodies
|
|
WO2021221493A1
(ko)
*
|
2020-04-29 |
2021-11-04 |
한국화학연구원 |
사스 코로나바이러스 2 스파이크 단백질과 결합하는 수용체와 항체를 포함하는 사스 코로나바이러스 2 진단 키트
|
|
KR102351653B1
(ko)
*
|
2020-04-29 |
2022-01-14 |
한국화학연구원 |
사스 코로나바이러스 2 스파이크 단백질과 결합하는 수용체와 항체를 포함하는 사스 코로나바이러스 2 진단 키트
|
|
WO2021221668A1
(en)
*
|
2020-04-30 |
2021-11-04 |
iRepertoire, Inc. |
Anti-sars-cov-2 monoclonal antibody compositions
|
|
CN113667010B
(zh)
*
|
2020-05-15 |
2023-07-28 |
普米斯生物技术(珠海)有限公司 |
冠状病毒的抗体及其衍生物用途
|
|
WO2021237051A1
(en)
*
|
2020-05-22 |
2021-11-25 |
Jecho Laboratories, Inc. |
SARS-CoV-2 ANTIBODY AND RELATED METHODS
|
|
WO2021238910A1
(en)
*
|
2020-05-25 |
2021-12-02 |
Guo Bingshi |
Anti-coronavirus spike protein antibodies and uses thereof
|
|
WO2021247892A1
(en)
|
2020-06-04 |
2021-12-09 |
Amgen Inc. |
Assessment of cleaning procedures of a biotherapeutic manufacturing process
|
|
AU2021286655A1
(en)
*
|
2020-06-12 |
2023-01-05 |
Nkarta, Inc. |
Genetically modified natural killer cells for CD70-directed cancer immunotherapy
|
|
CN116096402A
(zh)
*
|
2020-06-16 |
2023-05-09 |
高诚生物医药(杭州)有限公司 |
与抗人冠状病毒的中和抗体相关的方法和组合物
|
|
KR102662789B1
(ko)
*
|
2020-07-01 |
2024-05-03 |
앱클론(주) |
항-SARS-CoV-2 S 단백질 항체 또는 그의 항원 결합 단편, 및 이를 포함하는 SARS-CoV-2 감염증의 예방 또는 치료용 약제학적 조성물
|
|
MX2023000267A
(es)
*
|
2020-07-16 |
2023-02-13 |
Caregen Co Ltd |
Peptido con actividad neutralizante contra el coronavirus 2 del sindrome respiratorio agudo grave.
|
|
CN113945714B
(zh)
*
|
2020-07-16 |
2023-01-31 |
南京蓬勃生物科技有限公司 |
新型冠状病毒中和抗体类药物中和能力的检测方法
|
|
CN113956352B
(zh)
*
|
2020-07-20 |
2023-06-27 |
福建医科大学附属协和医院 |
新型冠状病毒中和性抗体及其制备方法与用途
|
|
CN113336831A
(zh)
*
|
2020-07-24 |
2021-09-03 |
上海延立药业有限公司 |
一种用于开发新冠病毒疫苗的长效重组糖蛋白
|
|
WO2022026775A1
(en)
*
|
2020-07-30 |
2022-02-03 |
Prellis Biologics, Inc |
Compositions and methods for targeting coronavirus
|
|
WO2022023566A2
(en)
*
|
2020-07-30 |
2022-02-03 |
Tiziana Life Sciences Plc |
Cd-3 antibodies for the treatment of coronavirus
|
|
KR20230084469A
(ko)
*
|
2020-08-04 |
2023-06-13 |
애보트 라피드 다이어그노스틱스 인터내셔널 언리미티드 컴퍼니 |
Sars-cov-2를 검출하기 위한 검정법
|
|
WO2022044573A1
(ja)
|
2020-08-26 |
2022-03-03 |
国立大学法人熊本大学 |
コロナウイルススパイク蛋白に対するヒト抗体またはその抗原結合断片
|
|
US20230287090A1
(en)
*
|
2020-09-02 |
2023-09-14 |
The Feinstein Institutes For Medical Research |
USE OF SARS-CoV-2 RECEPTOR BINDING MOTIF (RBM)-REACTIVE MONOCLONAL ANTIBODIES TO TREAT COVID-19
|
|
CN114159445B
(zh)
*
|
2020-09-11 |
2024-03-19 |
中国科学院分子细胞科学卓越创新中心 |
筛选抑制新型冠状病毒感染的小分子药物的方法及其应用
|
|
WO2022054068A1
(en)
*
|
2020-09-14 |
2022-03-17 |
Ramot At Tel-Aviv University Ltd. |
Antibodies for the prevention, treatment and detection of coronavirus infection
|
|
EP3970798A1
(en)
*
|
2020-09-18 |
2022-03-23 |
NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen |
Sars-cov-2-nanobodies
|
|
GB202015755D0
(en)
*
|
2020-10-05 |
2020-11-18 |
Rogers Arpi |
Coronavirus therapy
|
|
MX2023004364A
(es)
|
2020-10-15 |
2023-05-03 |
Amgen Inc |
Glucanos no emparejados relativos en metodos de produccion de anticuerpos.
|
|
KR102437114B1
(ko)
*
|
2020-10-21 |
2022-08-26 |
재단법인 바이오나노헬스가드연구단 |
스트렙트아비딘 결합 펩타이드가 태그된 중증급성호흡기증후군 코로나바이러스 특이적 항원 및 이의 용도
|
|
CN112442120A
(zh)
*
|
2020-11-25 |
2021-03-05 |
苏州大学 |
抗严重急性呼吸系统综合征ii型冠状病毒sars-cov-2的中和抗体
|
|
CN114605527B
(zh)
*
|
2020-12-04 |
2023-07-04 |
中国科学院分子细胞科学卓越创新中心 |
一种抗新型冠状病毒SARS-CoV-2的抗体及其制备方法和用途
|
|
CN115087667B
(zh)
*
|
2020-12-14 |
2023-06-23 |
杰科（天津）生物医药有限公司 |
特异性结合SARS-CoV-2的抗原结合蛋白
|
|
CN114716541B
(zh)
*
|
2021-01-05 |
2023-07-21 |
中国科学院分子细胞科学卓越创新中心 |
抗冠状病毒的全人广谱中和抗体76e1及其应用
|
|
TW202237642A
(zh)
*
|
2021-01-08 |
2022-10-01 |
美商１０Ｘ基因組學有限公司 |
對冠狀病毒具有特異性的抗原結合多肽及其用途
|
|
WO2022156670A1
(en)
*
|
2021-01-19 |
2022-07-28 |
Hifibio (Hk) Limited |
Multispecific antibodies against sars-cov-2 and methods of use thereof
|
|
WO2022159685A2
(en)
*
|
2021-01-22 |
2022-07-28 |
Vanderbilt University |
Sars-cov-2 coronavirus antibodies and uses thereof
|
|
CN115667506A
(zh)
*
|
2021-02-10 |
2023-01-31 |
西雅图免疫公司 |
重组ace2-fc融合分子及其制备和使用方法
|
|
WO2022177870A1
(en)
*
|
2021-02-17 |
2022-08-25 |
The Board Of Regents Of The University Of Texas System |
Multimeric sars-cov-2 binding molecules and uses thereof
|
|
AU2022289365A1
(en)
|
2021-06-07 |
2023-12-14 |
Amgen Inc. |
Using fucosidase to control afucosylation level of glycosylated proteins
|
|
WO2023039064A2
(en)
*
|
2021-09-08 |
2023-03-16 |
The Scripps Research Institute |
Broadly neutralizing antibodies against sars-like viruses
|
|
CN113943375B
(zh)
*
|
2021-10-01 |
2022-08-16 |
中国科学院昆明动物研究所 |
一类来源于新型冠状病毒s2蛋白hr区域的重组融合蛋白及其应用
|
|
AU2022361382A1
(en)
|
2021-10-05 |
2024-03-28 |
Amgen Inc. |
Fc-gamma receptor ii binding and glycan content
|
|
US20230265217A1
(en)
*
|
2021-10-27 |
2023-08-24 |
Twist Bioscience Corporation |
Multispecific sars-cov-2 antibodies and methods of use
|
|
EP4444910A4
(en)
|
2021-12-10 |
2025-11-05 |
Bio Rad Laboratories Inc |
Compositions, processes and systems for the treatment of samples with functionalized particles of adjustable morphology
|
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
|
CN115028715B
(zh)
*
|
2022-06-23 |
2023-08-18 |
生工生物工程（上海）股份有限公司 |
一种抗新型冠状病毒的抗体或其抗原结合片段、试剂盒及应用
|
|
AU2024256160A1
(en)
|
2023-04-20 |
2025-10-02 |
Amgen Inc. |
Methods of determining relative unpaired glycan content
|
|
WO2025038600A1
(en)
|
2023-08-14 |
2025-02-20 |
Amgen Inc. |
Methods for reducing yellow color
|
|
WO2025101820A1
(en)
|
2023-11-08 |
2025-05-15 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|